Concepedia

Daniel Landi

DL

Statistics

Publications

26

Citations

2.5K

H-Index

15

Active since

2003

Affiliations

Duke University(Current)

Baylor College of Medicine

Children's Cancer Center

Texas Children's Hospital

Duke Medical Center

Daniel Landi is an author at Duke University specializing in medicine, oncology, and molecular oncology.

ORCID

Publications per year

2003–2025

26

Publications

26

HER2-Specific Chimeric Antigen Receptor–Modified Virus-Specific T Cells for Progressive Glioblastoma

Nabil Ahmed, Vita S. Brawley, Meenakshi Hegde et al. · JAMA Oncology · 2017 · 837 citations · Full text

, , +17

Tandem CAR T cells targeting HER2 and IL13Rα2 mitigate tumor antigen escape

Meenakshi Hegde, Malini Mukherjee, Zakaria Grada et al. · Journal of Clinical Investigation · 2016 · 672 citations · Full text

, , +17

Outcomes of transplantation using various hematopoietic cell sources in children with Hurler syndrome after myeloablative conditioning

Jaap Jan Boelens, Mieke Aldenhoven, Duncan Purtill et al. · Blood · 2013 · 207 citations · Full text

, , +16

The type II RAF inhibitor tovorafenib in relapsed/refractory pediatric low-grade glioma: the phase 2 FIREFLY-1 trial

Lindsay Kilburn, Dong-Anh Khuong-Quang, Jordan R. Hansford et al. · Nature Medicine · 2023 · 177 citations · Full text

, , +15

TEM8/ANTXR1-Specific CAR T Cells as a Targeted Therapy for Triple-Negative Breast Cancer

Tiara T. Byrd, Kristen Fousek, Antonella Pignata et al. · Cancer Research · 2017 · 156 citations · Full text

, , +17

1–5 of 26